Learn More
Beschreibung
A non-specific inhibitor of adenosine 3',5'-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3',5'-cyclic monophosphate.
- Inhibits phenylephrine-induced release of 5-hydroxytryptamine from neuroendocrine epithelial cells of the airway mucosa (IC50: 1.3μM)
- Serves as an adenosine receptor antagonist
- Inhibits ion channels in the neuromuscular junction, GH3 cells, and vascular smooth muscle cells
- Induces calcium release from intracellular stores in sensory neurons
- Inhibits the growth of carcinoma cells both in vivo and in vitro in mice
Spezifikation
Spezifikation
| Melting Point | 195°C to 202°C |
| Quantity | 250 mg |
| Formula Weight | 222.25 |
| Physical Form | Powder |
Sicherheit und Handhabung
- 3-Isobutyl-1-methylxanthine
- Warning
- Acute toxicity Category 4
- H302-Harmful if swallowed.
- P264-Wash thoroughly after handling.
- P270-Do not eat, drink or smoke when using this product.
- P301+P312-IF SWALLOWED: Call a POISON CENTER or doctor/physician/ if you feel unwell.
- P330-Rinse mouth.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contain: 3-Isobutyl-1-methylxanthine
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.